Serum anti-mullerian hormone levels in the main phenotypes of polycystic ovary syndrome
Sezai Şahmay(Istanbul University-Cerrahpaşa), Hakan Seyisoğlu(Istanbul University), Begüm Aydoğan Mathyk(University of South Florida), Mahmut Öncül(Istanbul University), Abdullah Tüten(Istanbul University), Nil Atakul
European Journal of Obstetrics & Gynecology and Reproductive Biology
June 25, 2013
Cited by 86
Related Papers
Serum AMH levels and insulin resistance in women with PCOS
|European Journal of Obstetrics & Gynecology and Reproductive Biology|2018|95
Clinical characteristics and pregnancy outcomes of Syrian refugees: a case–control study in a tertiary care hospital in Istanbul, Turkey
|Archives of Gynecology and Obstetrics|2016|77
Elevated serum levels of anti‐Müllerian hormone can be introduced as a new diagnostic marker for polycystic ovary syndrome
|Acta Obstetricia Et Gynecologica Scandinavica|2013|69
Different serum anti-Müllerian hormone concentrations are associated with oocyte quality, embryo development parameters and IVF-ICSI outcomes
|Archives of Gynecology and Obstetrics|2011|57